News - Royalty Pharma
WEBAug 8, 2024 · Royalty Pharma Declares Third Quarter 2024 Dividend. Earnings. NEW YORK, NY, July 17, 2024 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of …
Royalty Pharma Announces $2.025 Billion Strategic Funding …
WEBJun 2, 2021 · NEW YORK, NY, and PLANEGG, GERMANY, June 2, 2021 – Royalty Pharma plc (Nasdaq: RPRX) and MorphoSys AG (FSE: MOR; Nasdaq: MOR) today announced a $2.025 billion strategic funding partnership as part of MorphoSys’ $1.7 billion acquisition of Constellation Pharmaceuticals.
Royalty Pharma plc (RPRX) Latest Stock News & Headlines - Yahoo …
WEBGet the latest Royalty Pharma plc (RPRX) stock news and headlines to help you in your trading and investing decisions.
Royalty Pharma
WEBRoyalty Pharma Reports Second Quarter 2024 Results. Earnings. NEW YORK, NY, August 8, 2024 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2024 and raised full year 2024 guidance for Portfolio Receipts.
Royalty Pharma Highlights Accomplishments and Provides …
WEBJan 8, 2024 · Royalty Pharma plc. 2023 Portfolio Receipts expected to be approximately $3,050 million, exceeding the upper end of guidance range. Announced transactions of $13 billion since 2020 expected to...
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
WEBNEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it will acquire royalties and milestones on frexalimab owned by ImmuNext, Inc. (ImmuNext) for...
Royalty Pharma Highlights Accomplishments and ... - Markets Insider
WEBNEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today provided an update on its business performance, including recent key accomplishments, and the full year 2023...
Royalty Pharma Stock Price | RPRX Stock Quote, News, and History ...
WEBSep 23, 2024 · The latest Royalty Pharma stock prices, stock quotes, news, and RPRX history to help you invest and trade smarter.
Royalty Pharma (RPRX) Stock Price, News & Analysis - MarketBeat
WEB3 days ago · Should You Buy or Sell Royalty Pharma Stock? Get The Latest RPRX Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat. Skip to main content
PureTech-Invented KarXT Receives U.S. Food and Drug …
WEB3 days ago · PureTech’s monetization of equity holdings in Karuna, including gross proceeds from the BMS acquisition of Karuna, and a strategic royalty agreement with Royalty Pharma have enabled PureTech to ...